EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sezaki, S.
Right arrow Articles by Ninomiya, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sezaki, S.
Right arrow Articles by Ninomiya, Y.
Experimental Biology and Medicine 230:621-630 (2005)
© 2005 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Thrombospondin-1 Is Induced in Rat Myocardial Infarction and Its Induction Is Accelerated by Ischemia/Reperfusion

Satoshi Sezaki*, Satoshi Hirohata*,{dagger},1, Akihiro Iwabu*, Keigo Nakamura*, Kenichi Toeda*, Toru Miyoshi*, Hitoshi Yamawaki*, Kadir Demircan{dagger}, Shozo Kusachi{ddagger}, Yasushi Shiratori* and Yoshifumi Ninomiya{dagger}

* Department of Medicine and Medical Science; {dagger} Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine and Dentistry; and {ddagger} Department of Medical Technology, Okayama University Medical School, Okayama, Okayama 700-8558 Japan

To whom requests for reprints should be addressed at 1 Department of Molecular Biology and Biochemistry and Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, 2–5–1, Shikata-cho, Okayama, Okayama 700-8558, Japan. E-mail: hirohas{at}cc.okayama-u.ac.jp

Thrombospondin-1 (TSP-1) is a multifunctional, rapid-turnover matricellular protein. Recent studies demonstrated that TSP-1 has a role in regulating inflammatory reactions. Myocardial infarction (MI) is associated with an inflammatory response, ultimately leading to healing and scar formation. In particular, an enhanced inflammatory reaction and a massive accumulation of monocytes/macrophages is seen with reperfusion after MI. To examine the role of TSP-1 in MI, we isolated rat TSP-1 complementary DNA (cDNA) and analyzed the level and distribution of the mRNA expression. In infarcted rat hearts, TSP-1 mRNA increased markedly at 6 and 12 hrs after coronary artery ligation (27.97 ± 3.40-fold and 22.77 ± 1.83-fold, respectively, compared with sham-operated hearts). Western blot analysis revealed that TSP-1 protein was transiently induced in the infarcted heart. Using in situ hybridization analysis, TSP-1 mRNA signals were observed in the infiltrating cells at the border area of infarction. We then examined the effect of ischemia/reperfusion (I/R) on TSP-1 mRNA induction in the rats with infarcted hearts. Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) demonstrated that I/R enhanced the TSP-1 mRNA expression approximately 4-fold, as compared with the level in the permanently ligated heart. Finally, we examined the effect of TSP-1 on proinflammatory cytokine release in mononuclear cells. The releases of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) from human mononuclear cells were enhanced by TSP-1 in a dose-dependent manner. Thus, the immediate and marked increase of TSP-1 expression suggests that TSP-1 has an inflammatory-associated role in MI.

Key Words: cytokine • extracellular matrix • gene expression • inflammation • ischemia




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Isenberg, D. D. Roberts, and W. A. Frazier
CD47: A New Target in Cardiovascular Therapy
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Ma and D. J. Waxman
Collaboration between hepatic and intratumoral prodrug activation in a P450 prodrug-activation gene therapy model for cancer treatment
Mol. Cancer Ther., November 1, 2007; 6(11): 2879 - 2890.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. J. Kaczorowski and T. R. Billiar
Targeting CD47: NO Limit on Therapeutic Potential
Circ. Res., March 16, 2007; 100(5): 602 - 603.
[Full Text] [PDF]


Home page
BloodHome page
J. S. Isenberg, F. Hyodo, K.-I. Matsumoto, M. J. Romeo, M. Abu-Asab, M. Tsokos, P. Kuppusamy, D. A. Wink, M. C. Krishna, and D. D. Roberts
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation
Blood, March 1, 2007; 109(5): 1945 - 1952.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Miyoshi, S. Hirohata, H. Ogawa, M. Doi, M. Obika, T. Yonezawa, Y. Sado, S. Kusachi, S. Kyo, S. Kondo, et al.
Tumor-specific expression of the RGD-{alpha}3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice
FASEB J, September 1, 2006; 20(11): 1904 - 1906.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Experimental Biology and Medicine.